CRMD
NASDAQ
$7.78
CorMedix Inc (CRMD)
CorMedix Inc., a biopharmaceutical company, focuses on developing and marketing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. The company is headquartered in Berkeley Heights, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $15 (+92.80%)
Market Cap
$660M
PEG Ratio
0.00
Revenue 5Y CAGR
+336.16%
Profit Margin
30.3%
Price Chart
Valuation
Market Cap$660M
P/E3.63
Forward P/E16.50
PEG0.00
P/S1.62
P/B1.49
Profitability
Total Revenue (TTM)$400M
Gross Profit (TTM)$368M
EBITDA$205M
Profit Margin30.3%
Operating Margin50%
EPS$2.32
Financial Health
Free Cash Flow Yield29.50%
Growth & Risk
Revenue 5Y CAGR+336.16%
Beta (5Y)0.84
Sharpe Ratio-0.27